PATH EX, Inc. is a privately held medical device company pioneering a breakthrough approach to sepsis treatment with its innovative CycloPE® device. CycloPE® is designed to directly capture and remove bacteria from the bloodstream, offering a rapid, targeted solution to combat life-threatening infections. The device has demonstrated promising outcomes in preclinical and clinical feasibility studies. PATH EX is advancing toward commercialization, aiming to revolutionize sepsis care and improve patient survival.
| Website | http://pathex.co |
| Revenue | $4 million |
| Employees | 8 (2 on RocketReach) |
| Founded | 2017 |
| Phone | (615) 938-7057 |
| Technologies |
HTML
,
Twitter
,
G Suite
+4 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Business Services General, Health Diagnostics, Business Services, Health Care, Medical Device |
| Keywords | Infectious Disease Diagnostics, Infectious Disease Treatment, Point Of Care Diagnostics, Critical Care Diagnostics, Precision Diagnostics, Medical Device Technology, Healthcare Technology Solutions, Healthcare Technology |
| Competitors | Cybrexa Therapeutics, ArQule, Ixchel Scientific (now zPREDICTA), Wntrix (view competitors) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies |
Looking for a particular PATH EX, Inc. employee's phone or email?
PATH EX, Inc. Questions
The PATH EX, Inc. annual revenue was $4 million in 2026.
Sinead Miller is the CEO and Cofounder of PATH EX, Inc..
2 people are employed at PATH EX, Inc..
PATH EX, Inc. is based in Houston, Texas.
The NAICS codes for PATH EX, Inc. are [54, 54171, 5417, 541713, 541].
The SIC codes for PATH EX, Inc. are [873, 87].
Top PATH EX, Inc. Employees
-
Sinead Miller
CEO and Cofounder at PATH EX, Inc.
Houston, TX, US21 -
Alex Wieseler
COO at PATH EX, Inc.
Houston, TX, US24
